Discover bioactive molecules, metabolites, and novel synthetic compounds
The different kinds of biomolecules in our bodies are at the nexus of human health and disease. Some of these molecules can act as biomarkers that report on our health status, others have therapeutic benefits to modulate disease progression. At the CeMM Molecular Discovery Platform, we use a technology-driven approach to empower the discovery and characterization of such bioactive molecules, including proteins, metabolites, and novel synthetic compounds.
These three classes of molecules are also the focus of the three modules that constitute the CeMM Molecular Discovery Platform — Proteomics, Metabolomics, and Chemical Screening. Using the latest technologies and state-of-the art instrumentation, we maximize coverage to biomolecules and enable data generation from minimal biological sample amounts.
The platform, with its three sub-facilities, provides services to all groups at CeMM as well as to external customers and thereby intends to contribute initial starting points towards discovering the therapies of the future.